It kept a board seat at biotech shop Centocor for 19 years, long after distributing shares to investors.
FORBES: Personality Change
2.
Thomas Schaible, vice president of medical affairs at the company's Centocor biotech division, says he's not worried about reproducing Remicade's results.
FORBES: Magazine Article
3.
Hence the birth of companies such as Centocor, which makes drugs for heart disease and may soon have new ones for colo-rectal and prostate cancers.